These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 25329977)

  • 21. Tackling the conformational sampling of larger flexible compounds and macrocycles in pharmacology and drug discovery.
    Chen IJ; Foloppe N
    Bioorg Med Chem; 2013 Dec; 21(24):7898-920. PubMed ID: 24184215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SARANEA: a freely available program to mine structure-activity and structure-selectivity relationship information in compound data sets.
    Lounkine E; Wawer M; Wassermann AM; Bajorath J
    J Chem Inf Model; 2010 Jan; 50(1):68-78. PubMed ID: 20053000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BindingDB and ChEMBL: online compound databases for drug discovery.
    Wassermann AM; Bajorath J
    Expert Opin Drug Discov; 2011 Jul; 6(7):683-7. PubMed ID: 22650976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maximum-score diversity selection for early drug discovery.
    Meinl T; Ostermann C; Berthold MR
    J Chem Inf Model; 2011 Feb; 51(2):237-47. PubMed ID: 21309543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TOPS-MODE model of multiplexing neuroprotective effects of drugs and experimental-theoretic study of new 1,3-rasagiline derivatives potentially useful in neurodegenerative diseases.
    Luan F; Cordeiro MN; Alonso N; García-Mera X; Caamaño O; Romero-Duran FJ; Yañez M; González-Díaz H
    Bioorg Med Chem; 2013 Apr; 21(7):1870-9. PubMed ID: 23415089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determining the Degree of Promiscuity of Extensively Assayed Compounds.
    Jasial S; Hu Y; Bajorath J
    PLoS One; 2016; 11(4):e0153873. PubMed ID: 27082988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promiscuity progression of bioactive compounds over time.
    Hu Y; Jasial S; Bajorath J
    F1000Res; 2015; 4(Chem Inf Sci):118. PubMed ID: 26064479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polypharmacology directed compound data mining: identification of promiscuous chemotypes with different activity profiles and comparison to approved drugs.
    Hu Y; Bajorath J
    J Chem Inf Model; 2010 Dec; 50(12):2112-8. PubMed ID: 21070069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activity profile relationships between structurally similar promiscuous compounds.
    Hu Y; Bajorath J
    Eur J Med Chem; 2013 Nov; 69():393-8. PubMed ID: 24077530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemotography for multi-target SAR analysis in the context of biological pathways.
    Lounkine E; Kutchukian P; Petrone P; Davies JW; Glick M
    Bioorg Med Chem; 2012 Sep; 20(18):5416-27. PubMed ID: 22405595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can we discover pharmacological promiscuity early in the drug discovery process?
    Peters JU; Hert J; Bissantz C; Hillebrecht A; Gerebtzoff G; Bendels S; Tillier F; Migeon J; Fischer H; Guba W; Kansy M
    Drug Discov Today; 2012 Apr; 17(7-8):325-35. PubMed ID: 22269136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adaptive mining and model building of medicinal chemistry data with a multi-metric perspective.
    Brown JB
    Future Med Chem; 2018 Aug; 10(16):1885-1887. PubMed ID: 29966447
    [No Abstract]   [Full Text] [Related]  

  • 33. Monitoring drug promiscuity over time.
    Hu Y; Bajorath J
    F1000Res; 2014; 3():218. PubMed ID: 25352982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic mining of analog series with related core structures in multi-target activity space.
    Gupta-Ostermann D; Hu Y; Bajorath J
    J Comput Aided Mol Des; 2013 Aug; 27(8):665-74. PubMed ID: 23975272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Large-scale assessment of activity landscape feature probabilities of bioactive compounds.
    Kayastha S; Dimova D; Iyer P; Vogt M; Bajorath J
    J Chem Inf Model; 2014 Feb; 54(2):442-50. PubMed ID: 24410456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Target family-directed exploration of scaffolds with different SAR profiles.
    Hu Y; Bajorath J
    J Chem Inf Model; 2011 Dec; 51(12):3138-48. PubMed ID: 22091691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Matched molecular pair analysis of small molecule microarray data identifies promiscuity cliffs and reveals molecular origins of extreme compound promiscuity.
    Dimova D; Hu Y; Bajorath J
    J Med Chem; 2012 Nov; 55(22):10220-8. PubMed ID: 23050678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Data structures and computational tools for the extraction of SAR information from large compound sets.
    Wawer M; Lounkine E; Wassermann AM; Bajorath J
    Drug Discov Today; 2010 Aug; 15(15-16):630-9. PubMed ID: 20547243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Graph mining for SAR transfer series.
    Gupta-Ostermann D; Wawer M; Wassermann AM; Bajorath J
    J Chem Inf Model; 2012 Apr; 52(4):935-42. PubMed ID: 22436016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extraction of tacit knowledge from large ADME data sets via pairwise analysis.
    Keefer CE; Chang G; Kauffman GW
    Bioorg Med Chem; 2011 Jun; 19(12):3739-49. PubMed ID: 21616672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.